Investor Relations

Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC), formerly known as Valeant Pharmaceuticals International, Inc., completed its acquisition of Bausch + Lomb on August 5, 2013. Bausch + Lomb, a division of Bausch Health, is one of the best-known and most respected health care brands.

For Investor Relations information on Bausch Health, click here.